(Q44685753)

5 December 2017

title

The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes (English)

1 reference

5 December 2017

0 references

1 reference

1 reference

Y Bi

1

1 reference

5 December 2017

G Y Tong

2

1 reference

5 December 2017

H J Yang

3

1 reference

5 December 2017

M Y Cai

4

1 reference

5 December 2017

J H Ma

5

1 reference

5 December 2017

J Liang

6

1 reference

5 December 2017

B Xin

7

1 reference

5 December 2017

H Miao

8

1 reference

5 December 2017

Z H Peng

9

1 reference

5 December 2017

D L Zhu

10

1 reference

5 December 2017

publication date

1 November 2013

1 reference

Diabetes - Metabolism: Research and Reviews

5 December 2017

published in

1 reference

5 December 2017

volume

29

1 reference

5 December 2017

issue

8

1 reference

5 December 2017

page(s)

664-672

1 reference

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

5 December 2017

cites work

1 reference

Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes

21 January 2018

1 reference

Islet beta cell failure in type 2 diabetes

21 January 2018

1 reference

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function

21 January 2018

1 reference

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

21 January 2018

1 reference

Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

21 January 2018

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

Use of metformin in the setting of mild-to-moderate renal insufficiency

21 January 2018

1 reference

Metformin therapy and clinical uses

21 January 2018

1 reference

Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial

21 January 2018

1 reference

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.

21 January 2018

1 reference

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

21 January 2018

1 reference

Lipotoxicity in human pancreatic islets and the protective effect of metformin

21 January 2018

1 reference

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

21 January 2018

1 reference

Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective

21 January 2018

1 reference

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

A mathematical model for the determination of total area under glucose tolerance and other metabolic curves

21 January 2018

1 reference

β-cell function preservation after 3.5 years of intensive diabetes therapy

21 January 2018

1 reference

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study

21 January 2018

1 reference

Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population.

21 January 2018

1 reference

Use and abuse of HOMA modeling

21 January 2018

1 reference

Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus.

21 January 2018

1 reference

Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.

21 January 2018

1 reference

New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser

21 January 2018

1 reference

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

21 January 2018

1 reference

Glucose-sensing in glucagon-like peptide-1-secreting cells

21 January 2018

1 reference

Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover

21 January 2018

1 reference

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

21 January 2018

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults

21 January 2018

1 reference

Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DMRR.2443

1 reference

5 December 2017

1 reference